APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is characterized by chronic relapsing inflammation of the gastrointestinal tract. The prevalence of IBD is increasing with approximately 4.9 million cases reported worldwide. Current therapies are limited due to the severity of side effects and long-term toxicity, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahakian, Lauren, Robinson, Ainsley M., Sahakian, Linda, Stavely, Rhian, Kelley, Mark R., Nurgali, Kulmira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669584/
https://www.ncbi.nlm.nih.gov/pubmed/38002251
http://dx.doi.org/10.3390/biom13111569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669584/
https://www.ncbi.nlm.nih.gov/pubmed/38002251
http://dx.doi.org/10.3390/biom13111569

Ejemplares similares